BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29268155)

  • 1. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
    Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoblast-derived integration-free iPS cell line from a 69-year-old male.
    Schröter F; Sleegers K; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Jan; 16(1):29-31. PubMed ID: 27345781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Jan; 16(1):113-5. PubMed ID: 27345793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoblast-derived integration-free iPSC lines from a female and male Alzheimer's disease patient expressing different copy numbers of a coding CNV in the Alzheimer risk gene CR1.
    Schröter F; Sleegers K; Van Cauwenberghe C; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):560-563. PubMed ID: 27789410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblast-derived integration-free iPSC line AD-TREM2-1 from a 67year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
    Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2018 May; 29():60-63. PubMed ID: 29602048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoblast-derived integration-free iPSC line AD-TREM2-3 from a 74 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
    Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2018 Jul; 30():141-144. PubMed ID: 29902745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast-derived integration-free iPSC line ISRM-NBS1 from an 18-year-old Nijmegen Breakage Syndrome patient carrying the homozygous NBN c.657_661del5 mutation.
    Martins S; Bohndorf M; Graffmann N; Wruck W; Chrzanowska KH; Adjaye J
    Stem Cell Res; 2019 Jan; 34():101372. PubMed ID: 30616142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
    Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
    Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.
    Bohndorf M; Ncube A; Spitzhorn LS; Enczmann J; Wruck W; Adjaye J
    Stem Cell Res; 2017 Dec; 25():18-21. PubMed ID: 29035842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two Alpha-I antitrypsin deficiency patient-derived induced pluripotent stem cell lines ISRM-AATD-iPSC-1 (HHUUKDi011-A) and ISRM-AATD-iPSC-2 (HHUUKDi012-A).
    Ncube A; Bewersdorf L; Spitzhorn LS; Loerch C; Bohndorf M; Graffmann N; May L; Amzou S; Fromme M; Wruck W; Strnad P; Adjaye J
    Stem Cell Res; 2023 Sep; 71():103171. PubMed ID: 37506509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
    Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
    Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
    Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
    Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.
    Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.